首页> 美国卫生研究院文献>Advanced Pharmaceutical Bulletin >Using Ketamine and Propofol for Procedural Sedation of Adults in the Emergency Department: A Systematic Review and Meta-Analysis
【2h】

Using Ketamine and Propofol for Procedural Sedation of Adults in the Emergency Department: A Systematic Review and Meta-Analysis

机译:在急诊科中使用氯胺酮和异丙酚进行成人镇静手术的系统评价和荟萃分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Purpose: Ketamine-propofol combination (ketofol) is being used to provide a safe and effective procedural sedation (PS) in emergency department (ED) and may theoretically have beneficial effects since using lower doses of each drug may result in a reduction of the adverse events of both agents while maintaining optimal conditions for performing procedures. This systematic review was conducted to evaluate the efficacy, advantages and disadvantages of these two drugs for PS. > Methods: The PRISMA statement was used for this systematic review. We searched the databases of PubMed, Scopus, ProQuest, Medline (Ovid) from 1990 to August 2017 for randomized clinical trials (RCTs) in which the study population aged ≥18 and was referred to ED. Full-texts of the studies performed in adults that were published in English were reviewed for inclusion. Both authors independently evaluated all studies. Five articles were eligible for the meta-analysis based on their common outcomes. >Results: The total number of subjects was 1250, of which 635 were treated with propofol and615 were treated with ketofol. Although two of the five studies showed a better quality ofsedation with ketofol, the other three did not find any significant difference between propofoland ketofol. This systematic review found a lower incidence of respiratory adverse effects inketofol group than propofol group.>Conclusion:Ketamine/propofol mixture (ketofol) has less respiratory adverse effects thanpropofol alone in ED procedural sedation.
机译:>目的:氯胺酮-异丙酚组合物(ketofol)被用于在急诊室(ED)中提供安全有效的程序镇静剂(PS),并且从理论上讲可能会有有益的效果,因为使用每种药物的剂量可能更低可以降低两种药物的不良反应,同时保持最佳的操作条件。进行了系统的评价,以评估这两种药物对PS的疗效,优缺点。 >方法: PRISMA声明用于该系统评价。我们从1990年至2017年8月在PubMed,Scopus,ProQuest,Medline(Ovid)的数据库中搜索了随机临床试验(RCT),其中研究人群年龄≥18岁并被转诊为ED。对成人进行的以英文发表的研究的全文进行了审查,以包括在内。两位作者都独立评估了所有研究。根据五篇文章的共同结果,有资格进行荟萃分析。>结果:受试者总数为1250人,其中635人接受了异丙酚和615例用酮咯酚治疗。尽管五项研究中有两项显示了更好的质量用克托泊尔镇静,其他三种异丙酚之间没有发现任何明显差异和ketofol。这项系统评价发现,在酮泊酚组优于丙泊酚组。>结论:氯胺酮/丙泊酚混合物(ketofol)的呼吸不良反应少于ED镇静剂中单独使用丙泊酚。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号